A Study of LY4175408 in Participants With Advanced Cancer

Clinical trial NCT07046923 · RECRUITING

Trial details

NCT number: NCT07046923
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Endometrial Neoplasms Neoplasm Metastasis Triple Negative Breast Cancer

Start date: 2025-07-28
Primary completion: 2030-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.